Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Alemtuzumab × 90 days × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

Specimen Handling 46 Carboplatin 34 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 30 Paclitaxel 29 Oxaliplatin 29 pembrolizumab 28 Cisplatin 28 Gemcitabine 27 Drug Therapy 25 Biopsy 25 Capecitabine 24 Bevacizumab 22 Radiotherapy 20 Docetaxel 20 Fluorouracil 19 venetoclax 18 Standard of Care 18 tislelizumab 17 Nivolumab 17 Injections 17 toripalimab 16 Azacitidine 16 fludarabine 15 Leucovorin 14 Irinotecan 13 Dexamethasone 13 cemiplimab 12 Radiosurgery 12 Pemetrexed 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡